Lucy Letby: Why experts are questioning the conviction

The Lucy Letby case has drawn fresh attention in 2025 as independent experts challenge the medical and statistical evidence that secured her convictions. Their reviews argue that the deaths and collapses at Countess of Chester Hospital resulted from natural causes or substandard care, not deliberate harm. The claims have prompted the Criminal Cases Review Commission to examine whether the convictions are unsafe.

Panel of fourteen experts

Retired Canadian neonatologist Dr Shoo Lee assembled fourteen international specialists to examine the medical records of the seventeen babies. Their February 2025 report concluded that no murders occurred. The panel found instead that every death and injury traced to natural causes or inadequate treatment.

Lee’s 1989 paper on air embolisms had been cited by the prosecution. The panel stated that the paper had been misinterpreted in court. UK members included former Royal College of Paediatrics and Child Health president Dr Neena Modi and perinatal pathologist Dr Marta Cohen.

The findings were submitted directly to the CCRC. Panel members stressed that their review covered every medical chart and test result presented at trial. They found nothing that supported claims of air injection or other intentional acts.

Insulin testing under review

Separate scrutiny has focused on the immunoassay tests used to allege insulin poisoning in babies F and L. A seven-expert dossier submitted in 2025 argued that the Roche assay measures antibodies rather than insulin itself. The test is designed for clinical screening, not forensic proof.

The experts noted that the method is prone to false positives and cross-reactivity. They added that no confirmatory testing was performed to rule out natural hypoglycaemia or poor clinical management. The report concluded that the poisoning claim lacked scientific justification.

One of the prosecution witnesses, Professor Peter Hindmarsh, faced a fitness-to-practise investigation that was revealed after the trial. The timing has raised questions about the reliability of the insulin evidence presented to the jury.

Shift chart statistics

Prosecutors relied on a chart showing Lucy Letby present at every collapse and death. Statisticians including Professor Jane Hutton and Professor Richard Gill have described the chart as an example of the prosecutor’s fallacy. The analysis did not control for staffing patterns or overall hospital mortality.

The Royal Statistical Society had warned before trial about drawing conclusions from small clusters of deaths. Subsequent reviews found elevated mortality even on shifts when Lucy Letby was not present. Experts now argue that the chart created an appearance of guilt without proper baseline comparison.

Professor Hutton summarised the statistical package as “a large pile of crockery, much of which is broken.” Other statisticians have labelled the approach a “statistical abomination.” These critiques now sit alongside the medical panel’s conclusions in the CCRC file.

CCRC application volume

Lucy Letby’s legal team, led by barrister Mark McDonald, submitted more than one thousand pages of new expert material in early 2025. The CCRC confirmed it is conducting an active review. Officials describe the case as unusually large in both scope and documentation.

The Court of Appeal had already refused earlier challenges. The current application rests on the cumulative weight of the Lee panel, the insulin dossier, and the statistical objections. The CCRC cannot determine guilt or innocence; it can only decide whether a fresh appeal is warranted.

Parallel inquiries, including the Thirlwall Inquiry into hospital practices, remain delayed until at least September 2026. Inquests into the babies’ deaths are scheduled for 2027. These timelines mean the CCRC review may conclude before those reports are public.

Prosecution experts respond

Dr Dewi Evans, the lead medical witness for the prosecution, has maintained that the original evidence remains sound. He has criticised the Lee panel for not interviewing clinical staff who treated the babies. Evans argues that the trial jury had access to contemporaneous notes the panel did not re-examine.

Supporters of the convictions point out that the jury deliberated for more than three weeks. They note that the original trial included extensive cross-examination of defence witnesses. Any retrial would require the new expert material to meet the threshold for fresh evidence under UK law.

Critics counter that complex medical evidence can overwhelm juries when competing interpretations are presented without clear statistical context. They cite past UK cases such as Sally Clark, where flawed expert testimony later led to overturned convictions.

International parallels

US readers have drawn comparisons to contested medical prosecutions such as those involving nurse Lucia de Berk in the Netherlands. In both instances, clusters of deaths prompted criminal charges that later faced statistical and clinical re-evaluation. The Letby case now joins that pattern of post-conviction scrutiny.

Legal observers note that the CCRC process differs from US innocence projects, yet the underlying questions are similar. When does circumstantial clustering become proof of intent, and how should courts weigh new expert consensus against an earlier jury verdict?

The scale of the expert challenge, twenty-six specialists across multiple disciplines, has drawn attention from miscarriage-of-justice networks in both countries. Their interest centres on whether the original trial properly tested the medical and statistical assumptions presented by the prosecution.

Media and public reaction

UK coverage intensified after the February 2025 press conference. Broadcasters aired extended segments on the Lee panel findings and the insulin dossier. Commentators noted the unusual step of a retired Canadian neonatologist leading a public challenge to a UK conviction.

Social media discussion has split along predictable lines. Some users highlight the absence of any direct witness to deliberate harm. Others emphasise the jury’s original decision and the emotional weight carried by the families of the affected babies.

International outlets have framed the story as a test case for how health-care systems handle unexplained neonatal deaths. The debate now extends beyond the UK tabloid press into medical journals and statistical forums.

Next procedural steps

The CCRC will continue to assess whether the new material creates a real possibility that the Court of Appeal would quash the convictions. A decision could come within twelve to eighteen months, though no formal timeline has been announced. If the commission refers the case, a full appeal hearing would follow.

Any successful appeal would not automatically declare Lucy Letby innocent. It would order a retrial or, in limited circumstances, an acquittal on the existing record. The families of the babies would then face renewed proceedings years after the original verdicts.

Meanwhile, the hospital has implemented new neonatal protocols and increased consultant oversight. Those changes address some of the care failures identified by the Lee panel, regardless of the final legal outcome.

Case trajectory ahead

The accumulating expert critiques have shifted the public conversation from the original trial narrative toward questions of evidentiary reliability. The CCRC review now serves as the formal channel for those questions. Its eventual decision will determine whether Lucy Letby returns to court or remains convicted on the existing record.